MedPath

TILRAY, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$1.4B
Website

Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

Phase 2
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: High THC/Low CBD Cannabis
Drug: High THC/High CBD Cannabis
Drug: Low THC/Low CBD Cannabis
First Posted Date
2015-08-07
Last Posted Date
2020-03-23
Lead Sponsor
Tilray
Target Recruit Count
6
Registration Number
NCT02517424
Locations
🇨🇦

University of British Columbia, Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath